On Tuesday, Aldeyra Therapeutics Inc (NASDAQ: ALDX) opened lower -3.56% from the last session, before settling in for the closing price of $5.62. Price fluctuations for ALDX have ranged from $1.47 to $6.55 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 19.81% at the time writing. With a float of $57.40 million, this company’s outstanding shares have now reached $59.20 million.
The firm has a total of 10 workers. Let’s measure their productivity. In terms of profitability, gross margin is 35.37%, operating margin of -10964.75%, and the pretax margin is -9645.34%.
Aldeyra Therapeutics Inc (ALDX) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Aldeyra Therapeutics Inc is 3.41%, while institutional ownership is 59.28%. The most recent insider transaction that took place on Aug 12 ’24, was worth 75,975. In this transaction Chief Development Officer of this company sold 16,041 shares at a rate of $4.74, taking the stock ownership to the 236,771 shares. Before that another transaction happened on Aug 12 ’24, when Company’s See Remarks sold 10,834 for $4.74, making the entire transaction worth $51,313. This insider now owns 126,382 shares in total.
Aldeyra Therapeutics Inc (ALDX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 19.81% per share during the next fiscal year.
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Trading Performance Indicators
Check out the current performance indicators for Aldeyra Therapeutics Inc (ALDX). In the past quarter, the stock posted a quick ratio of 4.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.64, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.65 in one year’s time.
Technical Analysis of Aldeyra Therapeutics Inc (ALDX)
Analysing the last 5-days average volume posted by the [Aldeyra Therapeutics Inc, ALDX], we can find that recorded value of 0.41 million was lower than the volume posted last year of 0.49 million. As of the previous 9 days, the stock’s Stochastic %D was 20.57%. Additionally, its Average True Range was 0.31.
During the past 100 days, Aldeyra Therapeutics Inc’s (ALDX) raw stochastic average was set at 67.29%, which indicates a significant increase from 34.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.37% in the past 14 days, which was lower than the 78.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.60, while its 200-day Moving Average is $4.18. Now, the first resistance to watch is $5.63. This is followed by the second major resistance level at $5.85. The third major resistance level sits at $5.98. If the price goes on to break the first support level at $5.29, it is likely to go to the next support level at $5.16. Should the price break the second support level, the third support level stands at $4.94.
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Key Stats
There are currently 59,422K shares outstanding in the company with a market cap of 322.06 million. Presently, the company’s annual sales total 0 K according to its annual income of -37,540 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -16,850 K.
